ScreenerHero

AIRSAirSculpt Technologies Inc. Common Stock

NAS · US · Healthcare · Medical Care Facilities · airsculpt.com
2.740USD-2.49%Mkt Cap: 197.54M $P/E: —

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. Th…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$95.21BUSDP/E 14.4
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$22.61BUSDP/E 10.9
FME
Fresenius Medical Care AG & Co. KGaA
$11.72BUSDP/E 12.1
FMS
Fresenius Medical Care AG & Co. KGaA
$12.47BUSDP/E 12.2
EHC
Encompass Health Corporation
$11.87BUSDP/E 20.1
DVA
DaVita Inc.
$11.16BUSDP/E 14.7
ENSG
The Ensign Group, Inc.
$10.46BUSDP/E 28.1
UHS
Universal Health Services, Inc. Class B
$10.45BUSDP/E 7.2
CHE
Chemed Corporation
$7.07BUSDP/E 27.2
PACS
PACS Group Inc.
$7.00BUSDP/E 25.9
LFST
LifeStance Health Group Inc. Common Stock
$4.76BUSDP/E 95.9
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.46BUSDP/E 22.6
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.66BUSDP/E 26.2
OPCH
Option Care Health, Inc.
$3.55BUSDP/E 18.0
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.3
BKD
Brookdale Senior Living Inc.
$2.82BUSD
EMEIS
Emeis SA
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.59BUSD

Key Statistics

Company
Market Cap197.54M $
Enterprise Value244.14M $
Revenue (TTM)150.72M $
Gross Profit90.13M $
Net Income (TTM)-11.67M $
Revenue/Share2.284 USD
Last Price2.740 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees330
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-267.00
PEG—
EV/EBITDA38.84
EV/Revenue1.62
P/S1.28
P/B1.82
EPS (TTM)-0.17
EPS (Forward)-0.01
52W Range
1.51012% of range12.00
52W High12.00 USD
52W Low1.510 USD
Profitability
Gross Margin59.37%
Oper. Margin-0.07%
EBITDA Margin4.17%
Profit Margin-7.68%
ROE-13.30%
ROA-6.23%
Growth
Revenue Growth-2.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.10M $
CapEx (TTM)2.40M $
FCF Margin5.30%
FCF Yield4.04%
Net Debt51.64M $
Net Debt/EBITDA8.22
Balance Sheet
Debt/Equity0.95
Current Ratio0.79
Quick Ratio0.61
Book Value/Sh1.466 USD
Cash/Share0.2610 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateAug 25, 2022
Pay DateSep 14, 2022
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.500 USD
Upside (mean)+64.2%
Target Range3.000 USD – 6.000 USD
$3.000+64.2% to mean$6.000
# Analysts2
Ownership
Shares Out.72.10M
Float16.77M
Insiders42.14%
Institutions63.37%
Short Interest
Short Ratio6.9d
Short % Float6.82%
Short % Out.3.86%
Shares Short2.76M
Short (prev mo.)3.38M
Technical
SMA 504.360 (-37.2%)
SMA 2003.551 (-22.8%)
Beta2.37
S&P 52W Chg18.16%
Avg Vol (30d)730.13K
Avg Vol (10d)1.50M
Technical Indicators
RSI (14)31.1
MACD-0.4479
MACD Signal-0.2747
MACD Hist.-0.1731
BB Upper5.845 USD
BB Middle4.094 USD
BB Lower2.343 USD
BB Width85.55%
ATR (14)0.4277 USD
Vol Ratio (20d)0.77x